SMILES: C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@H](O[C@@H]2C(=O)O)O[C@H]3[C@H]([C@H](O[C@@H]([C@@H]3O)OCCSSCCO[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)C(=O)O)O)O[C@@H]5[C@@H]([C@H]([C@H]([C@H](O5)C(=O)O)O[C@@H]6[C@@H]([C@H]([C@H]([C@H](O6)C)N)O)NC(=O)C)O)O)O)C(=O)O)O)O)O)NC(=O)C)O)N
Description: The molecule is an oligosaccharide derivative consisting of two 2-acetamido-4-amino-2,4-dideoxy-alpha-D-fucosyl-(1->4)-alpha-D-galacturonosyl-(1->3)-alpha-D-galacturonosyloxy trisaccharide units linked via a dithiodiethyl divalent group. One of a panel of synthetic oligosaccharide derivatives designed to reveal a critical role of the rare aminosugar 2-acetamido-4-amino-2,4-dideoxy-D-fucose (2-acetamido-4-amino-2,4,6-trideoxy-D-galactose; D-AAT) for serotype 1 immune recognition (PMID:29632881). It is an organic disulfide and an oligosaccharide derivative.